SCHEMBL5042310

SCHEMBL5042310

COc1cccc(-c2ccc([C@H](OC)C(=O)NCc3ccc(C#N)cc3)c(F)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 2/20 0.44
RAB9A P51151 1/20 0.43
PLAU P00749 1/20 0.43
EGLN2 Q96KS0 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
VCP P55072 1/20 0.41
MAPK8 P45983 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
HIF1A Q16665 1/20 0.40
ERN1 O75460 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
EP300 Q09472 1/20 0.39
MMP13 P45452 1/20 0.39
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042308 1.00 DGAT2 (0.44) DGAT2RAB9APLAUEGLN2SMN1; SMN2
SCHEMBL5042138 0.92 POLB (0.48) RAB9AHIF1AERN1TSHRPOLB
SCHEMBL5042135 0.92 POLB (0.48) RAB9AHIF1AERN1TSHRPOLB
SCHEMBL5040847 0.91 PKM (0.47) RAB9AHIF1APKMEP300
SCHEMBL5040855 0.91 PKM (0.47) RAB9AHIF1APKMEP300
SCHEMBL5037450 0.89 GSK3B (0.43) RAB9AHIF1ATSHRPOLBMAPT
SCHEMBL5037449 0.89 GSK3B (0.43) RAB9AHIF1ATSHRPOLBMAPT
SCHEMBL5037901 0.85 ABCB1 (0.42) DGAT2MAPK8MAPK9MAPK10
SCHEMBL5037907 0.85 ABCB1 (0.42) DGAT2MAPK8MAPK9MAPK10
SCHEMBL5045219 0.85 GSK3B (0.41) HIF1APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 DGAT2 4787/4885RAB9A 124/4885PLAU 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.